Yuqing Lou
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 25, 2025
Comparison of first-generation EGFR-TKIs combined with low-dose bevacizumab versus osimertinib in untreated advanced EGFR-mutated NSCLC.Yingqi Xu, Yidan Zhang, Hongping Jin
|Jan 20, 2023
Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery.Jun Lu, Yuqing Lou, Yanwei Zhang
|Feb 11, 2021
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.Yuqing Lou, Jianlin Xu, Yanwei Zhang
|Jul 02, 2020
Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs.Hai Zhang, Xiaohua Yang, Fang Hu
|Mar 07, 2020
Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?Yuqing Lou, Runbo Zhong, Jianlin Xu
Pageof 1
